title: Modified responses to PGE2 in polyamine biosynthesis by T lymphocytes of gastric- and conjunctiva basal cell-carcinoma patients.
abstract: The response to Prostaglandin (PG) E2 of T cells from gastric carcinoma (GC)- and conjunctiva-basal cell carcinoma (conjunctiva-BCC)-bearing patients has been studied in relation to polyamine metabolism. Polyamines are crucial co-factors in cell growth as well as differentiation and many works report that lymphocyte spermine (SP), spermidine (SPD) and putrescine (PUT) levels may be related to tumor proliferation. The present work aims to detect the basal and PGE2 induced concentrations of these polyamines and cAMP, ornithine decarboxylase (ODC), spermine N1-acetyltransferase (SAT) activities of T lymphocytes drawn from patients suffering from GC and conjunctiva-BCC since many carcinomas are characterized by high levels of PGE2. Data obtained from lymphocytes of neoplastic subjects were compared with those derived from PGE2-treated control lymphocytes. Results highlight a very significant increase of all the polyamine metabolites in PGE2-treated T cells from neoplastic patients in respect to the untreated and PGE2-treated control lymphocytes. Therefore, it is conceivable that the PGE2 content increase, often occurring during the epithelial tumour development, may contribute, through enhancement of polyamine metabolism, to tumor progression.
authors.affiliation: Department of Experimental Phatology and Microbiology, University of Messina, Medical School, Italy.
authors.forename: I
authors.initials: I
authors.lastname: Venza
authors.forename: P
authors.initials: P
authors.lastname: Ruggeri
authors.forename: A
authors.initials: A
authors.lastname: Valenti
authors.forename: L
authors.initials: L
authors.lastname: Denaro
authors.forename: A
authors.initials: A
authors.lastname: Severino
authors.forename: D
authors.initials: D
authors.lastname: Teti
mesh_terms: D000123:Acetyltransferases / Q000378:metabolism; D015317:Biogenic Polyamines / Q000096:biosynthesis*; D002280:Basal Cell Carcinoma / Q000378:metabolism*; D003230:Conjunctival Neoplasms / Q000378:metabolism*; D000242:Cyclic AMP / Q000378:metabolism; D015232:Dinoprostone / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D009955:Ornithine Decarboxylase / Q000378:metabolism; D010120:Oxytocics / Q000494:pharmacology*; D013274:Stomach Neoplasms / Q000378:metabolism*; D013601:T-Lymphocytes / Q000187:drug effects* / Q000378:metabolism; D000099228:Diamine N-Acetyltransferase
chemical_list: D000123:Acetyltransferases; D015317:Biogenic Polyamines; D000242:Cyclic AMP; D015232:Dinoprostone; D009955:Ornithine Decarboxylase; D010120:Oxytocics; D000099228:Diamine N-Acetyltransferase